VDyne
PrivateLast Round
VC Round
Oct 24, 2022
Total Funding Raised
$21M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
VDyne is a medical device company developing a minimally invasive transcatheter valve replacement system to treat tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VDyne Comparables
Compare VDyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laplace Interventional | 93% | |
| T-Heart | 93% | |
| Trisol Medical | 92% |
VDyne Funding Rounds
Historical fundraising activity
VDyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jean Boulle Medtech | VC Round, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 5, 2026
Grew 21% QoQ from 42 to 51 employees.
- Aug 26, 2026
Grew 28% QoQ from 39 to 50 employees.
VDyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VDyne's valuation, stock price, and market status.
Is VDyne a public or private company?
VDyne is a private company.
What is the current stock price of VDyne?
VDyne is a private company, so its shares have no public market price. Caplight tracks VDyne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VDyne worth (valuation)?
Valuation information for VDyne is not publicly available.
Can I buy VDyne stock?
VDyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VDyne's last funding round?
VDyne's most recent funding round was VC Round on October 24, 2022.
Who are the main investors in VDyne?
Key investors in VDyne include Jean Boulle Medtech.
Will VDyne IPO soon?
No public IPO plans have been announced for VDyne.
How can I track VDyne secondary market activity?
Caplight tracks bids, offers, and trades in VDyne's shares on secondary markets.